Literature DB >> 15048832

Different propensity to form amyloid fibrils by two homologous proteins-Human stefins A and B: searching for an explanation.

Sasa Jenko1, Miha Skarabot, Manca Kenig, Gregor Guncar, Igor Musevic, Dusan Turk, Eva Zerovnik.   

Abstract

By using ThT fluorescence, X-ray diffraction, and atomic force microscopy (AFM), it has been shown that human stefins A and B (subfamily A of cystatins) form amyloid fibrils. Both protein fibrils show the 4.7 A and 10 A reflections characteristic for cross beta-structure. Similar height of approximately 3 nm and longitudinal repeat of 25-27 nm were observed by AFM for both protein fibrils. Fibrils with a double height of 5.6 nm were only observed with stefin A. The fibril's width for stefin A fibrils, as observed by transmission electron microscopy (TEM), was in the same range as previously reported for stefin B (Zerovnik et al., Biochem Biophys Acta 2002;1594:1-5). The conditions needed to undergo fibrillation differ, though. The amyloid fibrils start to form at pH 5 for stefin B, whereas in stefin A, preheated sample has to be acidified to pH < 2.5. In both cases, adding TFE, seeding, and alignment in a strong magnetic field accelerate the fibril growth. Visual analysis of the three-dimensional structures of monomers and domain-swapped dimers suggests that major differences in stability of both homologues stem from arrangement of specific salt bridges, which fix alpha-helix (and the alpha-loop) to beta-sheet in stefin A monomeric and dimeric forms. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15048832     DOI: 10.1002/prot.20041

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  11 in total

1.  In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1.

Authors:  Sabina Rabzelj; Vito Turk; Eva Zerovnik
Journal:  Protein Sci       Date:  2005-09-09       Impact factor: 6.725

2.  Interaction between oligomers of stefin B and amyloid-beta in vitro and in cells.

Authors:  Katja Skerget; Ajda Taler-Vercic; Andrej Bavdek; Vesna Hodnik; Slavko Ceru; Magda Tusek-Znidaric; Tiina Kumm; Didier Pitsi; Marusa Pompe-Novak; Peep Palumaa; Salvador Soriano; Natasa Kopitar-Jerala; Vito Turk; Gregor Anderluh; Eva Zerovnik
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

3.  Conformational changes during amyloid fibril formation of pancreatic thiol proteinase inhibitor: effect of copper and zinc.

Authors:  Medha Priyadarshini; Bilqees Bano
Journal:  Mol Biol Rep       Date:  2011-07-26       Impact factor: 2.316

4.  Different conformation of thiol protease inhibitor during amyloid formation: inhibition by curcumin and quercetin.

Authors:  Mohd Shahnawaz Khan; Abdulrahman M Al-Senaidy; Medha Priyadarshini; Aaliya Shah; Bilqees Bano
Journal:  J Fluoresc       Date:  2013-01-22       Impact factor: 2.217

5.  Pore formation by human stefin B in its native and oligomeric states and the consequent amyloid induced toxicity.

Authors:  Gregor Anderluh; Eva Zerovnik
Journal:  Front Mol Neurosci       Date:  2012-08-02       Impact factor: 5.639

6.  Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.

Authors:  Mira Polajnar; Slavko Ceru; Nataša Kopitar-Jerala; Eva Zerovnik
Journal:  Front Mol Neurosci       Date:  2012-08-24       Impact factor: 5.639

7.  The role of initial oligomers in amyloid fibril formation by human stefin B.

Authors:  Ajda Taler-Verčič; Tiina Kirsipuu; Merlin Friedemann; Andra Noormägi; Mira Polajnar; Julia Smirnova; Magda Tušek Znidarič; Matjaž Zganec; Miha Skarabot; Andrej Vilfan; Rosemary A Staniforth; Peep Palumaa; Eva Zerovnik
Journal:  Int J Mol Sci       Date:  2013-09-05       Impact factor: 5.923

8.  Studies of the oligomerisation mechanism of a cystatin-based engineered protein scaffold.

Authors:  Matja Zalar; Sowmya Indrakumar; Colin W Levy; Richard B Tunnicliffe; Günther H J Peters; Alexander P Golovanov
Journal:  Sci Rep       Date:  2019-06-21       Impact factor: 4.379

9.  Influence of point mutations on the stability, dimerization, and oligomerization of human cystatin C and its L68Q variant.

Authors:  Aneta Szymańska; Elżbieta Jankowska; Marta Orlikowska; Izabela Behrendt; Paulina Czaplewska; Sylwia Rodziewicz-Motowidło
Journal:  Front Mol Neurosci       Date:  2012-07-27       Impact factor: 5.639

10.  Cystatins in immune system.

Authors:  Spela Magister; Janko Kos
Journal:  J Cancer       Date:  2012-12-20       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.